LogicBio Therapeutics: Q1 Earnings Snapshot

 
Share

LEXINGTON, Mass. (AP) _ LogicBio Therapeutics Inc. (LOGC) on Monday reported a loss of $6.7 million in its first quarter.

The Lexington, Massachusetts-based company said it had a loss of 20 cents per share.

The genome editing company posted revenue of $2.8 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LOGC at https://www.zacks.com/ap/LOGC